19.85
-2.15
(-9.77%)
At close: January 10 at 4:00:01 PM EST
19.85
0.00
(0.00%)
After hours: January 10 at 4:51:53 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-58,518.00
-82,029.00
-180,164.00
-122,138.00
-29,616.00
Investing Cash Flow
54,924.00
41,128.00
114,541.00
-474,396.00
-51,122.00
Financing Cash Flow
159.00
8,082.00
71,886.00
393,164.00
313,048.00
End Cash Position
6,711.00
10,696.00
43,716.00
38,090.00
241,764.00
Interest Paid Supplemental Data
6,972.00
6,639.00
1,068.00
--
--
Capital Expenditure
-10,058.00
-20,663.00
-84,589.00
-57,831.00
-50,816.00
Issuance of Capital Stock
--
--
--
391,476.00
312,618.00
Issuance of Debt
--
8,669.00
70,338.00
--
--
Repayment of Debt
--
-587.00
--
--
--
Free Cash Flow
-68,576.00
-102,692.00
-264,753.00
-179,969.00
-80,432.00
12/31/2020 - 3/19/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CLRB Cellectar Biosciences, Inc.
0.2823
-9.23%
IPSC Century Therapeutics, Inc.
0.9900
-7.48%
ACHL Achilles Therapeutics plc
1.1850
-0.42%
KROS Keros Therapeutics, Inc.
14.56
-2.22%
ASMB Assembly Biosciences, Inc.
15.62
-7.79%
SMMT Summit Therapeutics Inc.
17.85
-5.15%
GLPG Galapagos NV
25.65
-8.95%
CTMX CytomX Therapeutics, Inc.
0.8801
-10.45%
OKUR OnKure Therapeutics, Inc.
7.43
-4.87%
JANX Janux Therapeutics, Inc.
46.76
-7.99%